NCT00275236
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Schwarz BioSciences Monheim, Germany
Clinical trial condition
Restless Legs Syndrome
Explore clinical trials studying Restless Legs Syndrome. Study availability and eligibility vary by location and protocol.
148 public trials
9 recruiting studies
Restless Legs Syndrome trial results
Completed
Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome
NCT00135993
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Schwarz RTP, North Carolina, United States
NCT02248142
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
Not specified
Completed
Three Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg Syndrome
NCT00136045
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Schwarz Monheim, Germany
NCT01174459
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Boehringer Ingelheim Investigational Site 119 Akashi, Japan
- Boehringer Ingelheim Investigational Site 52 Akishima, Japan
- Boehringer Ingelheim Investigational Site 16 Akita, Japan
- Boehringer Ingelheim Investigational Site 22 Ami-machi, Japan
NCT01569464
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- 006 Birmingham, Alabama, United States
- 013 Jasper, Alabama, United States
- 021 Gilbert, Arizona, United States
- 014 Little Rock, Arkansas, United States
NCT00887289
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Boehringer Ingelheim Investigational Site Aalen, Germany
- Boehringer Ingelheim Investigational Site 1 Achim, Germany
- Boehringer Ingelheim Investigational Site 2 Achim, Germany
- Boehringer Ingelheim Investigational Site 1 Ahrensburg, Germany
NCT00472199
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- 248.629.4302 Boehringer Ingelheim Investigational Site Innsbruck, Austria
- 248.629.4304 Boehringer Ingelheim Investigational Site Linz, Austria
- 248.629.3201 Boehringer Ingelheim Investigational Site Edegem, Belgium
- 248.629.35801 Boehringer Ingelheim Investigational Site Espoo, Finland
NCT00654498
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- 248.630.04 Boehringer Ingelheim Investigational Site Beijing, China
- 248.630.05 Boehringer Ingelheim Investigational Site Beijing, China
- 248.630.06 Boehringer Ingelheim Investigational Site Beijing, China
- 248.630.07 Boehringer Ingelheim Investigational Site Beijing, China
NCT00721279
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Boehringer Ingelheim Investigational Site Absam, Austria
- Boehringer Ingelheim Investigational Site Absdorf, Austria
- Boehringer Ingelheim Investigational Site Afritz, Austria
- Boehringer Ingelheim Investigational Site Alkoven, Austria